CD274 and cancer: Based on the Z score evaluation, supremely activated pathways included cholesterol biosynthesis, mevalonate pathway 1, systemic lupus erythematosus in the T cell signaling pathway, and Toll-like receptor signaling while PD-1/PD-L1 cancer immunotherapy pathway was inhibited (Table 3).